Why Dollar General Shares Are Trading Lower By Over 8%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session

Why Dollar General Shares Are Trading Lower By Over 8%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session

Gainers

  • Top Ships Inc. TOPS shares jumped 74% to $5.24.
  • Vapotherm, Inc. VAPO gained 48.8% to $1.3250.
  • The Alkaline Water Company Inc. WTER gained 37.5% to $0.24.
  • Wearable Devices Ltd. WLDS jumped 30.8% to $0.8551.
  • Vaxxinity, Inc. VAXX gained 27% to $3.33. Vaxxinity recently posted a Q3 loss of $0.15 per share.
  • Pacifico Acquisition Corp. PAFO shares rose 26.9% to $6.83 after dipping around 43% on Wednesday.
  • Advanced Human Imaging Limited AHI gained 26.8% to $0.5201.
  • Arco Platform Limited ARCE shares climbed 21.6% to $10.99 after the company announced receipt of a non-binding going private proposal.
  • Core Scientific, Inc. CORZ jumped 21% to $0.1614.
  • Okta, Inc. OKTA gained 20.6% to $64.30 after the company reported better-than-expected Q3 results. The company also issued Q4 and FY23 EPS and sales guidance above analyst estimates.
  • Sonim Technologies, Inc. SONM jumped 20% to $0.4911 after the company announced a $17 million additional tablet order.
  • Oncolytics Biotech Inc. ONCY rose 20.2% to $2.11. Oncolytics Biotech received FDA fast track designation for the treatment of advanced/metastatic pancreatic cancer.
  • Ainos, Inc. AIMD gained 19.8% to $0.72.
  • Kintara Therapeutics, Inc. KTRA jumped 19.2% to $7.99. Kintara Therapeutics recently regained compliance with Nasdaq minimum bid price requirement.
  • COMSovereign Holding Corp. COMS surged 19% to $0.1085 after the company received approval for continued listing on The Nasdaq Capital Market.
  • Yext, Inc. YEXT gained 18.3% to $6.30 after the company reported better-than-expected Q3 adjusted EPS results and issued Q4 adjusted EPS guidance above estimates.
  • Five Below, Inc. FIVE surged 16.3% to $187.09 after the company reported better-than-expected Q3 results and issued FY22 guidance above estimates.
  • Ra Medical Systems, Inc. RMED rose 16.1% to $2.8450 after jumping 16% on Wednesday. Ra Medical recently posted a Q3 loss of $4.36 per share.
  • REX American Resources Corporation REX climbed 16% to $34.24 after the company reported better-than-expected Q3 EPS and sales results.
  • Mullen Automotive, Inc. MULN gained 15% to $0.2213 after the company announced it closed on the acquisition of Electric Last Mile Solutions' assets.
  • SelectQuote, Inc. SLQT gained 14.3% to $0.6860. SelectQuote recently posted a Q1 loss of $0.26 per share.
  • Avaya Holdings Corp. AVYA rose 13.7% to $1.1004.
  • GoodRx Holdings, Inc. GDRX gained 13.5% to $4.9519 after Citigroup initiated coverage on the stock with a Buy rating and announced a $7 price target.
  • electroCore, Inc. ECOR jumped 12.9% to $0.3740.
  • Kidpik Corp. PIK gained 12.6% to $0.8627.
  • Splunk Inc. SPLK rose 12% to $87.01 after the company reported better-than-expected results for its third quarter and raised FY23 sales guidance.
  • Bausch Health Companies Inc. BHC gained 10% to $7.74.
  • MMTec, Inc. MTC gained 9.2% to $1.19.
  • PVH Corp. PVH gained 8.1% to $72.63 following Q3 results.


Losers

  • G-III Apparel Group, Ltd. GIII shares fell 42.7% to $12.39 after the company reported worse-than-expected Q3 earnings and issued weak FY23 adjusted EPS guidance.
  • Aziyo Biologics, Inc. AZYO dipped 39.9% to $4.1499 after the company announced pricing of an $11.2 million public offering of common stock.
  • Yunhong CTI Ltd. CTIB fell 36.5% to $0.5498. Yunhong CTI recently posted a Q3 loss of $0.12 per share.
  • Winc, Inc. WBEV fell 26.6% to $0.2175. Winc recently posted a Q3 loss of $0.33 per share.
  • Lands' End, Inc. LE fell 26.5% to $8.50 after the company reported worse-than-expected Q3 adjusted EPS and sales results and cut FY22 net revenue guidance.
  • SQZ Biotechnologies Company SQZ fell 26.1% to $1.8550 after the company announced a strategic repriortization of its portfolio, CEO Armon Sharei will step down and a workforce reduction of approximately 60%. Also, B of A Securities downgraded the stock from Buy to Underpeform and lowered its price target from $9 to $2.
  • Biodesix, Inc. BDSX shares fell 24.5% to $1.51 after surging 47% on Wednesday.
  • Designer Brands Inc. DBI dipped 21.6% to $11.98 after the company reported worse-than-expected Q3 adjusted EPS and sales results and lowered FY22 EPS guidance below estimates.
  • Farfetch Limited FTCH dropped 21.5% to $6.67 after the company issued FY23 and FY25 guidance.
  • Corbus Pharmaceuticals Holdings, Inc. CRBP fell 21.5% to $0.1526 after jumping 60% on Wednesday.
  • Reed's, Inc. REED fell 19.5% to $0.1030. Reed's recently lowered FY22 revenue outlook.
  • Eloxx Pharmaceuticals, Inc. ELOX dropped 19% to $0.1101 after the company announced a 1-for-40 reverse stock split.
  • Satixfy Communications Ltd. SATX fell 18.3% to $18.70.
  • BYND Cannasoft Enterprises Inc. BCAN fell 18.3% to $4.11.
  • Duluth Holdings Inc. DLTH dipped 17.8% to $7.20 after the company posted downbeat quarterly earnings and lowered FY22 guidance.
  • Biophytis S.A. BPTS fell 17.8% to $0.55.
  • Aura Biosciences, Inc. AURA declined 16.6% to $11.91 after the company announced pricing of a public offering of common stock.
  • Genius Group Limited GNS dropped 16.3% to $0.4603.
  • Tuesday Morning Corporation TUEM fell 14.1% to $2.9955.
  • Cognition Therapeutics, Inc. CGTX shares fell 12.5% to $3.07 after jumping over 41% on Wednesday.
  • Big Lots, Inc. BIG dropped 11.6% to $17.24 after the company reported worse-than-expected Q3 adjusted EPS and sales results.
  • FREYR Battery FREY fell 10.7% to $12.19 after the company announcing pricing of an upsized $230 million public offering.
  • Salesforce, Inc. CRM shares fell 9.9% to $144.44 after the company reported third-quarter results and announced that Bret Taylor will step down as vice chair and co-CEO.
  • Caleres, Inc. CAL fell 8.9% to $22.01.
  • Panbela Therapeutics, Inc. PBLA shares fell 8.7% to $0.1201 after declining over 7% on Wednesday. Panbela recentlys said first patients enrolled in Europe for ASPIRE trial studying Ivospemin (SBP-101) in combination with gemcitabine and nab-paclitaxel in patients with metastatic pancreatic ductal adenocarcinoma.
  • Dollar General Corporation DG fell 8.5% to $233.91 after the company reported worse-than-expected Q3 EPS results and issued Q4 EPS guidance below estimates.
  • Genesco Inc. GCO fell 7.1% to $48.51.
  • Elastic N.V. ESTC fell 6.9% to $56.99 after the company posted upbeat Q2 results and issued strong earnings forecast.
  • Costco Wholesale Corporation COST dropped 6.7% to $503.32 after the company reported November sales results.
  • XPeng Inc. XPEV fell 6.1% to $10.15. XPeng shares jumped over 47% on Wednesday after reporting quarterly results.
  • Credit Suisse Group AG CS fell 5.6% to $3.0950. The company recently said it expects to post a loss for the quarter. Shareholders last week also approved the company's capital raise plan.

Posted In: Communications EquipmentInformation TechnologyMid-Day MoversTop GainersNewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading Ideas